Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | -.--% | -.--% | -95.41% |
Mar. 05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
Feb. 16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
Quotes 5-day view
Delayed Quote OTC Markets2024-05-30 | |
---|---|
Last | 0.0086 $ |
Volume | 23 683 |
Change | +∞% |
Opening | 0.01 |
High | 0.01 |
Low | 0.01 |
Performance
1 month | +1.18% | ||
3 months | +330.00% | ||
6 months | -90.00% | ||
Current year | -95.41% | ||
1 year | -99.09% | ||
3 years | -99.91% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -95.41% | -99.09% | 199K | ||
-1.64% | -5.10% | +46.19% | +11.40% | 55.7B | ||
+0.33% | -4.20% | -6.14% | +7.85% | 39.57B | ||
+0.21% | +2.13% | +39.33% | -14.59% | 39.91B | ||
+5.08% | +3.98% | -6.65% | +8.41% | 28.16B | ||
-1.71% | -0.97% | +12.33% | +43.58% | 26.3B | ||
-0.49% | -0.23% | -21.78% | -22.69% | 18.94B | ||
-1.30% | -3.15% | -0.35% | -7.36% | 12.12B | ||
-1.16% | +1.45% | +24.18% | +25.71% | 12.12B | ||
+1.05% | +0.69% | +28.38% | +85.57% | 12.17B | ||
+1.11% | -2.00% | -11.07% | +4.76% | 10.83B | ||
-0.75% | +1.51% | -2.46% | -8.86% | 9.69B | ||
-0.96% | +4.97% | +38.72% | +55.59% | 6.56B | ||
-2.83% | -0.48% | +10.44% | +74.97% | 6.38B | ||
+0.29% | -6.65% | +18.77% | -15.67% | 6.49B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | -0.06% | -0.75% | +4.96% | +9.97% | ||
Weighted average by Cap. | +0.28% | -1.40% | +15.99% | +11.54% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -95.41% | ||
2023 | -95.53% | ||
2022 | -56.98% | ||
2021 | +0.62% |
- Stock Market
- Equities
- PKBO Stock
- Quotes Peak Bio, Inc.